274 related articles for article (PubMed ID: 27849168)
1. Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma.
Krishnan A; Fei F; Jones A; Busto P; Marshak-Rothstein A; Ksander BR; Gregory-Ksander M
J Immunol; 2016 Dec; 197(12):4626-4638. PubMed ID: 27849168
[TBL] [Abstract][Full Text] [Related]
2. A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma.
Krishnan A; Kocab AJ; Zacks DN; Marshak-Rothstein A; Gregory-Ksander M
J Neuroinflammation; 2019 Sep; 16(1):184. PubMed ID: 31570110
[TBL] [Abstract][Full Text] [Related]
3. Soluble Fas ligand blocks destructive corneal inflammation in mouse models of corneal epithelial debridement and LPS induced keratitis.
Gregory-Ksander M; Perez VL; Marshak-Rothstein A; Ksander BR
Exp Eye Res; 2019 Feb; 179():47-54. PubMed ID: 30365944
[TBL] [Abstract][Full Text] [Related]
4. Control of ocular tumor growth and metastatic spread by soluble and membrane Fas ligand.
Gregory MS; Saff RR; Marshak-Rothstein A; Ksander BR
Cancer Res; 2007 Dec; 67(24):11951-8. PubMed ID: 18089826
[TBL] [Abstract][Full Text] [Related]
5. The FasLane to ocular pathology-metalloproteinase cleavage of membrane-bound FasL determines FasL function.
Gregory-Ksander M; Marshak-Rothstein A
J Leukoc Biol; 2021 Nov; 110(5):965-977. PubMed ID: 33565149
[TBL] [Abstract][Full Text] [Related]
6. Opposing roles for membrane bound and soluble Fas ligand in glaucoma-associated retinal ganglion cell death.
Gregory MS; Hackett CG; Abernathy EF; Lee KS; Saff RR; Hohlbaum AM; Moody KS; Hobson MW; Jones A; Kolovou P; Karray S; Giani A; John SW; Chen DF; Marshak-Rothstein A; Ksander BR
PLoS One; 2011 Mar; 6(3):e17659. PubMed ID: 21479271
[TBL] [Abstract][Full Text] [Related]
7. Membrane-bound and soluble Fas ligands have opposite functions in photoreceptor cell death following separation from the retinal pigment epithelium.
Matsumoto H; Murakami Y; Kataoka K; Notomi S; Mantopoulos D; Trichonas G; Miller JW; Gregory MS; Ksander BR; Marshak-Rothstein A; Vavvas DG
Cell Death Dis; 2015 Nov; 6(11):e1986. PubMed ID: 26583327
[TBL] [Abstract][Full Text] [Related]
8. Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure.
Yue J; Khan RS; Duong TT; Dine KE; Cui QN; O'Neill N; Aravand P; Liu T; Chaqour B; Shindler KS; Ross AG
Neurotherapeutics; 2023 Apr; 20(3):896-907. PubMed ID: 36941497
[TBL] [Abstract][Full Text] [Related]
9. Soluble Fas Ligand Is Essential for Blister Formation in Pemphigus.
Lotti R; Shu E; Petrachi T; Marconi A; Palazzo E; Quadri M; Lin A; O'Reilly LA; Pincelli C
Front Immunol; 2018; 9():370. PubMed ID: 29535737
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
[TBL] [Abstract][Full Text] [Related]
11. DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma.
Kim KY; Perkins GA; Shim MS; Bushong E; Alcasid N; Ju S; Ellisman MH; Weinreb RN; Ju WK
Cell Death Dis; 2015 Aug; 6(8):e1839. PubMed ID: 26247724
[TBL] [Abstract][Full Text] [Related]
12. Adeno-associated virus mediated gene therapy for neuroprotection of retinal ganglion cells in glaucoma.
Starr C; Chen B
Vision Res; 2023 May; 206():108196. PubMed ID: 36812679
[TBL] [Abstract][Full Text] [Related]
13. Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation.
Dupont PJ; Warrens AN
Immunology; 2007 Jan; 120(1):133-9. PubMed ID: 17233740
[TBL] [Abstract][Full Text] [Related]
14. Retinal ganglion cell protection by 17-beta-estradiol in a mouse model of inherited glaucoma.
Zhou X; Li F; Ge J; Sarkisian SR; Tomita H; Zaharia A; Chodosh J; Cao W
Dev Neurobiol; 2007 Apr; 67(5):603-16. PubMed ID: 17443811
[TBL] [Abstract][Full Text] [Related]
15. Distinct effects of soluble and membrane-bound fas ligand on fibroblast-like synoviocytes from rheumatoid arthritis patients.
Audo R; Calmon-Hamaty F; Papon L; Combe B; Morel J; Hahne M
Arthritis Rheumatol; 2014 Dec; 66(12):3289-99. PubMed ID: 25078097
[TBL] [Abstract][Full Text] [Related]
16. BCLX
Donahue RJ; Fehrman RL; Gustafson JR; Nickells RW
Cell Death Dis; 2021 Aug; 12(8):781. PubMed ID: 34376637
[TBL] [Abstract][Full Text] [Related]
17. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis.
O' Reilly LA; Tai L; Lee L; Kruse EA; Grabow S; Fairlie WD; Haynes NM; Tarlinton DM; Zhang JG; Belz GT; Smyth MJ; Bouillet P; Robb L; Strasser A
Nature; 2009 Oct; 461(7264):659-63. PubMed ID: 19794494
[TBL] [Abstract][Full Text] [Related]
18. Assessment of inner retina dysfunction and progressive ganglion cell loss in a mouse model of glaucoma.
Pérez de Lara MJ; Santano C; Guzmán-Aránguez A; Valiente-Soriano FJ; Avilés-Trigueros M; Vidal-Sanz M; de la Villa P; Pintor J
Exp Eye Res; 2014 May; 122():40-9. PubMed ID: 24631335
[TBL] [Abstract][Full Text] [Related]
19. Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma.
Bosco A; Anderson SR; Breen KT; Romero CO; Steele MR; Chiodo VA; Boye SL; Hauswirth WW; Tomlinson S; Vetter ML
Mol Ther; 2018 Oct; 26(10):2379-2396. PubMed ID: 30217731
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for retinal ganglion cell neuroprotection in glaucoma.
Wilson AM; Di Polo A
Gene Ther; 2012 Feb; 19(2):127-36. PubMed ID: 21975466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
